Platelet-derived microparticles augment the adhesion and neovascularization capacities of circulating angiogenic cells obtained from atherosclerotic patients

Atherosclerosis

Volumn 227, Issue 2, 2013, Pages 275-282

  Ohtsuka, Masanori ^a   Sasaki, Ken ichiro ^a   Ueno, Takafumi ^a   Seki, Ritsuko ^a   Nakayoshi, Takaharu ^a   Koiwaya, Hiroshi ^a   Toyama, Yasuyuki ^a   Yokoyama, Shinji ^a   Mitsutake, Yoshiaki ^a   Chibana, Hidetoshi ^a   Itaya, Naoki ^a   Okamura, Takashi ^a   Imaizumi, Tsutomu ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Atherosclerotic risk factors; Cell therapy; Circulating angiogenic cells; Ischemic limb; Platelet derived microparticles; RANTES

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NEUTRALIZING ANTIBODY; RANTES; RENIN INHIBITOR;

ADULT; ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; ATHEROSCLEROSIS; BLOOD CELL; BLOOD SAMPLING; CAPILLARY; CELL ADHESION; CELL ISOLATION; CELL MIGRATION; CELL SURFACE; CIRCULATING ANGIOGENIC CELL; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; HINDLIMB ISCHEMIA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INJECTION; LIMB ISCHEMIA; MALE; MONONUCLEAR CELL; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PLATELET MICROPARTICLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ADULT; ANIMALS; ATHEROSCLEROSIS; BLOOD PLATELETS; CELL ADHESION; CELL-DERIVED MICROPARTICLES; CHEMOKINE CCL5; EXTREMITIES; FEMALE; HUMANS; ISCHEMIA; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; RATS; RATS, INBRED F344; RISK FACTORS;

EID: 84875052871     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.01.040     Document Type: Article

References (30)

1. Losordo D.W., Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies. Circulation 2004, 109:2692-2697.
2. Hirschi K.K., Ingram D.A., Yoder M.C. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2008, 28:1584-1595.
3. Abdel-Latif A., Bolli R., Tleyjeh I.M., et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 2007, 167:989-997.
4. Matoba S., Tatsumi T., Murohara T., et al. Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia. Am Heart J 2008, 156:1010-1018.
5. Moriya J., Minamino T., Tateno K., et al. Long-term outcome of therapeutic neovascularization using peripheral blood mononuclear cells for limb ischemia. Circ Cardiovasc Interv 2009, 2:245-254.
6. Chavakis E., Urbich C., Dimmeler S. Homing and engraftment of progenitor cells: a prerequisite for cell therapy. J Mol Cell Cardiol 2008, 45:514-522.
7. Dimmeler S., Leri A. Aging and disease as modifiers of efficacy of cell therapy. Circ Res 2008, 102:1319-1330.
8. Heeschen C., Lehmann R., Honold J., et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 2004, 109:1615-1622.
9. Hughes M., Hayward C.P., Warkentin T.E., et al. Morphological analysis of microparticle generation in heparin-induced thrombocytopenia. Blood 2000, 96:188-194.
10. Nomura S., Ozaki Y., Ikeda Y. Function and role of microparticles in various clinical settings. Thromb Res 2008, 123:8-23.
11. Janowska-Wieczorek A., Majka M., Kijowski J., et al. Platelet-derived microparticles bind to hematopoietic stem/progenitor cells and enhance their engraftment. Blood 2001, 98:3143-3149.
12. Mause S.F., Ritzel E., Liehn E.A., et al. Platelet microparticles enhance the vasoregenerative potential of angiogenic early outgrowth cells after vascular injury. Circulation 2010, 122:495-506.
13. Katoh A., Ikeda H., Murohara T., et al. Platelet-derived 12-hydroxyeicosatetraenoic acid plays an important role in mediating canine coronary thrombosis by regulating platelet glycoprotein IIb/IIIa activation. Circulation 1998, 98:2891-2898.
14. Baj-Krzyworzeka M., Majka M., Pratico D., et al. Platelet-derived microparticles stimulate proliferation, survival, adhesion, and chemotaxis of hematopoietic cells. Exp Hematol 2002, 30:450-459.
15. Dimmeler S., Aicher A., Vasa M., et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 2001, 108:391-397.
16. Koiwaya H., Sasaki K., Ueno T., et al. Augmented neovascularization with magnetized endothelial progenitor cells in rats with hind-limb ischemia. J Mol Cell Cardiol 2011, 51:33-40.
17. Toyama Y., Sasaki K., Tachibana K., et al. Ultrasound stimulation restores impaired neovascularization-related capacities of human circulating angiogenic cells. Cardiovasc Res 2012, 95:448-459.
18. Barry O.P., Pratico D., Lawson J.A., et al. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest 1997, 99:2118-2127.
19. George J.N., Pickett E.B., Saucerman S., et al. Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery. J Clin Invest 1986, 78:340-348.
20. Sims P.J., Faioni E.M., Wiedmer T., et al. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 1988, 263:18205-18212.
21. Mause S.F., Weber C. Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res 2010, 107:1047-1057.
22. de Mendonça F.L., da Fonseca P.C., Phillips R.M., et al. Site-directed mutagenesis of CC chemokine receptor 1 reveals the mechanism of action of UCB 35625, a small molecule chemokine receptor antagonist. J Biol Chem 2005, 280:4808-4816.
23. Wise E.L., Duchesnes C., da Fonseca P.C., et al. Small molecule receptor agonists and antagonists of CCR3 provide insight into mechanisms of chemokine receptor activation. J Biol Chem 2007, 282:27935-27943.
24. Rossi R., Lichtner M., De Rosa A., et al. In vitro effect of anti-human immunodeficiency virus CCR5 antagonist maraviroc on chemotactic activity of monocytes, macrophages and dendritic cells. Clin Exp Immunol 2011, 166:184-190.
25. Sasaki K., Heeschen C., Aicher A., et al. Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy. Proc Natl Acad Sci USA 2006, 103:14537-14541.
26. Walter D.H., Haendeler J., Reinhold J., et al. Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease. Circ Res 2005, 97:1142-1151.
27. Schober A. Chemokines in vascular dysfunction and remodeling. Arterioscler Thromb Vasc Biol 2008, 28:1950-1959.
28. von Hundelshausen P., Koenen R.R., Sack M., et al. Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium. Blood 2005, 105:924-930.
29. Mause S.F., von Hundelshausen P., Zernecke A., et al. Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler Thromb Vasc Biol 2005, 25:1512-1518.
30. Brill A., Dashevsky O., Rivo J., et al. Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization. Cardiovasc Res 2005, 67:30-38.